Inventor · disambiguated record
David G. Watumull
Also filed as: WATUMULL DAVID G
9 granted patents·9 pending applications·65 citations·filing 2003–2019
86Inventor score
Top patents by PatentIndex Score
18 records- 0190US7145025B2Structural carotenoid analogs for the inhibition and amelioration of diseaseHAWAII BIOTECH INC·Filed 2003·Granted Dec 5, 2006·39 cites·8 claims
- 0275US7592449B2Structural carotenoid analogs for the inhibition and amelioration of diseaseCARDAX PHARMACEUTICALS INC·Filed 2006·Granted Sep 22, 2009·2 cites·29 claims
- 0373US7521584B2Carotenoid analogs or derivatives for the inhibition and amelioration of diseaseCARDAX PHARMACEUTICALS INC·Filed 2004·Granted Apr 21, 2009·7 cites·21 claims
- 0473US7317008B2Carotenoid ester analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injuryCARDAX PHARMACEUTICALS INC·Filed 2004·Granted Jan 8, 2008·6 cites·52 claims
- 0570US7723327B2Carotenoid ester analogs or derivatives for the inhibition and amelioration of liver diseaseCARDAX PHARMACEUTICALS INC·Filed 2004·Granted May 25, 2010·5 cites·60 claims
- 0661US7763649B2Carotenoid analogs or derivatives for controlling connexin 43 expressionCARDAX PHARMACEUTICALS INC·Filed 2004·Granted Jul 27, 2010·2 cites·45 claims
- 0758US7345091B2Carotenoid ether analogs or derivatives for the inhibition and amelioration of diseaseCARDAX PHARMACEUTICALS INC·Filed 2004·Granted Mar 18, 2008·2 cites·16 claims
- 0857US7375133B2Pharmaceutical compositions including carotenoid ether analogs or derivatives for the inhibition and amelioration of diseaseCARDAX PHARMACEUTICALS INC·Filed 2004·Granted May 20, 2008·1 cites·35 claims
- 0956US7320997B2Pharmaceutical compositions including carotenoid ester analogs or derivatives for the inhibition and amelioration of diseaseCARDAX PHARMACEUTICALS INC·Filed 2004·Granted Jan 22, 2008·1 cites·74 claims
- 1047US2005004235A1Carotenoid analogs or derivatives for the inhibition and amelioration of liver diseaseFiled 2004·Application pending·0 cites
- 1147US2005059635A1Carotenoid ester analogs or derivatives for controlling C-reactive protein levelsFiled 2004·Application pending·0 cites
- 1247US2005026874A1Carotenoid ether analogs or derivatives for the inhibition and amelioration of liver diseaseFiled 2004·Application pending·0 cites
- 1341US2005148517A1Carotenoid ether analogs or derivatives for controlling connexin 43 expressionFiled 2004·Application pending·0 cites
- 1441US2005059659A1Carotenoid analogs or derivatives for controlling C-reactive protein levelsFiled 2004·Application pending·0 cites
- 1541US2005143475A1Carotenoid analogs or derivatives for the inhibition and amelioration of ischemic reperfusion injuryFiled 2004·Application pending·0 cites
- 1639US2020085776A1Methods of Reducing C-Reactive Protein and/or Treating Cardiovascular DiseaseCARDAX INC·Filed 2019·Application pending·0 cites
- 1737US2005049248A1Carotenoid ether analogs or derivatives for controlling C-reactive protein levelsFiled 2004·Application pending·0 cites
- 1837US2005009788A1Carotenoid ester analogs or derivatives for controlling connexin 43 expressionFiled 2004·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David G. Watumull files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →